Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Dyne Therapeutics, Inc. DYN

Set alert

Price alert · DYN

All alert types
17.30 USD +0.61 +3.65%

At close · Nov 2

17.30 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
17.30 × 2
Ask
17.31 × 2
16.71 Day range 17.35
14.25 52-week range 26.78
YTD
-11.55%
1 year
-23.38%
Open
16.81
Prev close
16.69
Mkt cap
3.23B
Vol
2.91M
Avg vol
2.77M
EPS
-3.42
P/E
0.00
Div yield
0.00%
More statistics
Low
16.71
High
17.35
Forward P/E
-5.22
Beta
1.21
Short ratio
7.94
Inst. own
103.60%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
18.53
200-d avg
19.31
1y target
34.33

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 11, 2026Earnings: -0.73; estimate -0.77229; surprise 5.48%
  • Jul 30, 2026Earnings: -1.08; estimate -0.74878; surprise -44.23%
  • Sep 9, 2026Downgrade: JP Morgan · Neutral → Underweight
  • Sep 9, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Sep 29, 2026Rating: Piper Sandler · Overweight → Overweight
  • Sep 30, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 30, 2026Rating: Chardan Capital · Buy → Buy
  • Oct 28, 2026Downgrade: Oppenheimer · Outperform → Perform
Signals (40)
NameDateAgo
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 14, 20262 weeks ago
MACD: Buy SignalOct 1, 20261 month ago
SMA: BearishSep 8, 20261 month ago
RSI: OversoldSep 8, 20261 month ago
SMA: BearishSep 4, 20261 month ago
MACD: Sell SignalAug 6, 20262 months ago
MACD: Buy SignalAug 5, 20262 months ago
MACD: Sell SignalAug 3, 20263 months ago
MACD: Buy SignalJul 28, 20263 months ago
MACD: Sell SignalJul 16, 20263 months ago
RSI: OverboughtJul 7, 20263 months ago
RSI: OverboughtJul 2, 20264 months ago
SMA: BullishJun 17, 20264 months ago
SMA: BearishJun 16, 20264 months ago
SMA: BullishJun 15, 20264 months ago
MACD: Buy SignalJun 12, 20264 months ago
SMA: BullishJun 11, 20264 months ago
SMA: BearishJun 10, 20264 months ago
SMA: BullishJun 9, 20264 months ago

Newest 20 of 40.

Financial health

Altman Z-Score

3.60 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -5.6×
FY 2016: -2.5×FY 2017: 50.9×FY 2018: -50.9×FY 2019: -79.7×FY 2020: -16.9×FY 2021: -4.1×FY 2022: -3.6×FY 2023: -3.4×FY 2024: -7.0×FY 2025: -5.6×
FY 2016 5y median -4.1× FY 2025
P/S 0.0×
FY 2016: 2.3×FY 2017: 7.7×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 2.6×
FY 2016: 1.5×FY 2017: 2.0×FY 2018: -50.6×FY 2019: 77.3×FY 2020: 2.9×FY 2021: 1.6×FY 2022: 2.4×FY 2023: 8.7×FY 2024: 3.5×FY 2025: 2.6×
FY 2016 5y median 2.6× FY 2025
P/FCF -6.2×
FY 2016: 8.8×FY 2017: 10.7×FY 2018: -57.4×FY 2019: -80.5×FY 2020: -20.8×FY 2021: -4.9×FY 2022: -3.8×FY 2023: -4.2×FY 2024: -7.5×FY 2025: -6.2×
FY 2016 5y median -4.9× FY 2025
EV/EBITDA -3.7×
FY 2016: 97.0×FY 2017: 12.6×FY 2018: -50.6×FY 2019: -73.4×FY 2020: -11.9×FY 2021: -2.9×FY 2022: -2.8×FY 2023: -3.0×FY 2024: -5.7×FY 2025: -3.7×
FY 2016 5y median -3.0× FY 2025
EV/Sales 0.0×
FY 2016: 7.5×FY 2017: 23.6×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -16.1%
FY 2016: 11.4%FY 2017: 9.3%FY 2018: -1.7%FY 2019: -1.2%FY 2020: -4.8%FY 2021: -20.4%FY 2022: -26.0%FY 2023: -23.8%FY 2024: -13.3%FY 2025: -16.1%
FY 2016 5y median -20.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -67.0%FY 2017: -479.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -46.9%FY 2017: -81.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -90.8%FY 2017: 15.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -45.9%
FY 2016: -60.7%FY 2017: 4.0%FY 2018: 98.6%FY 2019: -96.4%FY 2020: -17.2%FY 2021: -40.5%FY 2022: -66.6%FY 2023: -258.4%FY 2024: -50.4%FY 2025: -45.9%
FY 2016 5y median -50.4% FY 2025
ROIC -41.0%
FY 2016: -5.0%FY 2017: 0.5%FY 2018: -63.3%FY 2019: -98.2%FY 2020: -16.9%FY 2021: -37.4%FY 2022: -60.4%FY 2023: -204.0%FY 2024: -52.6%FY 2025: -41.0%
FY 2016 5y median -52.6% FY 2025
ROA -37.6%
FY 2016: -9.5%FY 2017: 0.6%FY 2018: -58.2%FY 2019: -82.4%FY 2020: -16.6%FY 2021: -35.1%FY 2022: -54.9%FY 2023: -142.9%FY 2024: -45.9%FY 2025: -37.6%
FY 2016 5y median -45.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 62.2%FY 2017: -63.0%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -36.1%
FY 2016: -1100.0%FY 2017: 35.6%FY 2018: 98.8%FY 2019: -188.3%FY 2020: -324.2%FY 2021: -155.8%FY 2022: -14.0%FY 2023: -41.6%FY 2024: -42.0%FY 2025: -36.1%
FY 2016 FY 2025
EPS (diluted) -3.0%
FY 2016: -2502.5%FY 2017: 104.9%FY 2018: -200.0%FY 2019: 36.2%FY 2020: -313.3%FY 2021: -136.3%FY 2022: -10.2%FY 2023: -22.3%FY 2024: 14.7%FY 2025: -3.0%
FY 2016 FY 2025
Free Cash Flow -37.4%
FY 2016: 293.4%FY 2017: 3.1%FY 2018: -101.2%FY 2019: -213.7%FY 2020: -253.6%FY 2021: -158.4%FY 2022: -27.2%FY 2023: -20.5%FY 2024: -56.0%FY 2025: -37.4%
FY 2016 FY 2025

Financial Health

Current Ratio 22.3×
FY 2016: 3.3×FY 2017: 1.5×FY 2018: 11.5×FY 2019: 6.3×FY 2020: 31.8×FY 2021: 13.3×FY 2022: 9.5×FY 2023: 2.5×FY 2024: 15.6×FY 2025: 22.3×
FY 2016 5y median 13.3× FY 2025
Quick Ratio 22.3×
FY 2016: 2.8×FY 2017: 1.0×FY 2018: 11.5×FY 2019: 6.3×FY 2020: 31.8×FY 2021: 13.3×FY 2022: 9.5×FY 2023: 2.5×FY 2024: 15.6×FY 2025: 22.3×
FY 2016 5y median 13.3× FY 2025
Debt / Equity 0.0×
FY 2016: 4.4×FY 2017: 4.4×FY 2018: -0.7×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 2.0×
FY 2016: 68.0×FY 2017: 8.5×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 5.2×FY 2021: 1.1×FY 2022: 0.9×FY 2023: 0.4×FY 2024: 1.3×FY 2025: 2.0×
FY 2016 5y median 1.1× FY 2025
Interest Coverage -75.6×
FY 2016: -1.0×FY 2017: -0.7×FY 2018: -959×FY 2019: 0.0×FY 2020: -148×FY 2021: 0.0×FY 2022: -58.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -75.6×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31